non-small cell lung cancer (NSCLC) Archives

26 Sep

Empowering the Immune System: The Magic of Nivolunix 100mg

26/09/2025
By Dipesh

Cancer treatment has advanced significantly with the advent of immunotherapy drugs, and among them, Nivolumab has gained wide recogniti...

23 Sep

Health

Afanix 20mg: A Game-Changer in EGFR-Mutant NSCLC

23/09/2025
By Dipesh

Afanix 20mg (Afatinib) represents a powerful and targeted therapy option for patients with EGFR-mutant NSCLC. Its mechanism of irrevers...

20 Sep

Health

Brigacent 90mg : The Future of Metastatic Lung Cancer Therapy

20/09/2025
By Dipesh

The targeted medication Brigacent 90mg, which contains the active ingredient Brigatinib, is authorized to treat metastatic non-small ce...

11 Sep

Health

Selcaxen 40mg: Advanced Treatment for RET Altered Cancers

11/09/2025
By Dipesh

Selcaxen 40mg contains Selpercatinib, a targeted cancer therapy developed to treat certain types of cancers driven by RET (Rearranged d...

02 Sep

Health

Moboxen 40mg (Mobocertinib): Targeted Therapy for EGFR Exon 20 NSCLC

02/09/2025
By Dipesh

Moboxen 40mg is a brand name for the drug Mobocertinib, an oral medication designed specifically to treat a rare subset of non-small ce...

01 Sep

Health

Alkixen 250mg: Improving Quality of Life for Cancer Patients

01/09/2025
By Dipesh

Crizotinib, marketed under the brand name Alkixen 250mg, is a targeted therapy medication primarily utilized in oncology for treating s...

19 Aug

Health

Adakras 200mg Targeted Therapy for KRAS G12C Mutation in NSCLC

19/08/2025
By Dipesh

Adakras 200mg is a generic formulation of Adagrasib, a targeted therapy. Adagrasib is an oral, irreversible inhibitor of the KRAS G12C ...

Tag Archives: non-small cell lung cancer (NSCLC)

Empowering the Immune System: The Magic of Nivolunix 100mg

Afanix 20mg: A Game-Changer in EGFR-Mutant NSCLC

Brigacent 90mg : The Future of Metastatic Lung Cancer Therapy

Selcaxen 40mg: Advanced Treatment for RET Altered Cancers

Moboxen 40mg (Mobocertinib): Targeted Therapy for EGFR Exon 20 NSCLC

Alkixen 250mg: Improving Quality of Life for Cancer Patients

Adakras 200mg Targeted Therapy for KRAS G12C Mutation in NSCLC